drugset / Trial / NCT00658255

Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis Turbuhaler

NCT00658255

Phase 2 Completed 175 enrolled AstraZeneca
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the therapeutic effects of formoterol in Symbicort with formoterol in Oxis Turbuhaler for the treatment of adults with stable asthma.

Timeline

Start
2002-10
Primary completion
Completion
2003-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule
Comparator Formoterol Other / unclassified

Indications